2024 RNDS | Social Determinants of Health in TM @wearesrna
2024 RNDS | Social Determinants of Health in TM  @wearesrna
Uploaded December 2024 | Updated November 2026, 1 day ago
At the 2024 RNDS, Ka-Ho Wong discussed the project on social determinants of health in myelopathy and transverse myelitis, highlighting its funding by SRNA [00:00:10]. Ka-Ho explained the five categories of social determinants of health as defined by Healthy People 2030 and their relevance to neurology [00:01:05]. Various studies were cited, including ones focusing on neighborhood disadvantage, stress, and socioeconomic status affecting conditions like neuromyelitis optica spectrum disorder (NMOSD) [00:02:30]. Ka-Ho also delved into ongoing and future research projects to better understand the impact of social determinants on neuroimmune disease outcomes [00:05:45]. Finally, Ka-Ho answered questions from the audience [00:11:25]. Please note that the information shared during this session is for informational purposes only and is not medical advice.

00:00 Introduction and Acknowledgements
00:27 Understanding Social Determinants of Health
01:26 Social Determinants in Neurology
02:18 Research on Rare Neuroimmune Disorders
04:03 Transverse Myelitis Outcome Project
06:32 Survey Studies and Preliminary Results
11:25 Q&A Session
2024 RNDS | Social Determinants of Health in TM2024 RNDS | Disability: Adapting to and Embracing Disability2026 RNDS | Closing Remarks2024 RNDS | NMOSD and MOGAD Clinical Trials1214. Self Identity and Finding Meaning Following DiagnosisCommunity Meets Clinic 304. Dr. Ayşe Altıntaş2025 RNDS en Español | Bienvenida2024 Stronger Together | Journey Together: Reflecting and Shaping the Future2017 RNDS | Welcome and Goals2023 RNDS en Español | Una conversación con nuestros aliados de la industria sobre apoyo y recursos2025 RNDS en Español | Trastornos neuroinmunes poco frecuentes: mielitis transversa (MT)2026 RNDS | Research on Predicting MOGAD Patients at Risk for Relapse
SRNA |

2024 RNDS | Social Determinants of Health in TM

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER